Abstract:ObjectiveTo investigate the radiological classification, gene-mutation status, and surgical prognosis of synchronous multiple primary lung cancer (sMPLC).MethodsFrom January 2013 to October 2019, 192 consecutive patients with sMPLC were investigated. The clinical, CT, molecular, and pathological features of all patients were analyzed. Furthermore, the prognosis of 89 patients who only underwent surgical resection was evaluated.ResultsAmong 192 patients, all lesions pathologically confirmed or highly suspected as tumors based on radiological findings were retrospectively analyzed, and the CT findings of sMPLC were classified into three types: (I) all lesions manifested as solid nodules/masses (14.06%, 27/192), (II) all lesions manifested as subsolid nodules/masses (43.23%, 83/192), and (III) tumor lesions manifested as a combination of ≥ 2 of the following patterns: solid nodules/masses, subsolid nodules/masses, cystic airspace, and focal consolidation (42.71%, 82/192). For 252 tumors undergoing epidermal growth factor receptor (EGFR)–mutation testing, the EGFR-mutation rate was higher in subsolid tumors than that in solid tumors (p < 0.05). Among 19 patients with all tumors undergoing surgery and driver-gene testing, genetic heterogeneity was prevalent among the multiple tumors (63.16%,12/19). The highest clinical stage of non-I, ipsilateral distribution of tumors, and CT classification of I indicated a poor prognosis for patients with sMPLC (all p < 0.05).ConclusionSubsolid lesions are the most common presentation of sMPLC. Genetic heterogeneity in driver mutations among sMPLC may be present. Prognosis in patients with sMPLC is determined by the highest clinical TNM stage, distribution, and radiological classification among the multiple tumors.Key Points• Synchronous multiple primary lung cancer (sMPLC) has three types of CT findings.• Genetic heterogeneity may be prevalent among the multiple tumors.• Prognosis in patients with sMPLC is associated with the highest clinical TNM stage, distribution, and radiological classification among the multiple tumors.

Diagnosis and treatment of synchronous multiple primary lung cancer – a case report

OTT_A_183319 4281..4285

[Synchronous Multiple Primary Lung Cancer Dignosed by Different Phenotype-genotype: A Case Report and Literature Review].

Confronting Synchronous Multiple Primary Lung Cancers: Navigating the Intersection of Challenges and Opportunities

Single-stage Surgical Treatment of Synchronous Multiple Primary Lung Cancers : a Report of Three Cases and Literature Review

Real‐world comprehensive diagnosis and "Surgery + X" treatment strategy of early‐stage synchronous multiple primary lung cancer

Analysis of Primary Synchronous Breast Invasive Ductal Carcinoma and Lung Adenocarcinoma with Next-Generation Sequencing: A Case Report.

Surgical Treatment Of Synchronous Multiple Primary Lung Cancers: A Retrospective Analysis Of 122 Patients

Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR Mutations

Comprehensive Genomic Profiling Aids in Understanding the Lesion Origins of a Patient with Six Synchronous Invasive Lung Adenocarcinomas: a Case Study

Diagnosis and management of multiple primary lung cancer

Novel Strategy for Synchronous Multiple Primary Lung Cancer Displaying Unique Molecular Profiles

Diagnosis and Treatment of Synchronous Multiple Primary Malignant Tumors in Lung

A case report of synchronous breast and lung cancer with three different pathologic diagnoses

Radiological classification, gene-mutation status, and surgical prognosis of synchronous multiple primary lung cancer

Metachronous and Synchronous Triple Primary Lung Cancers in a Chronic Smoker

Targeted Sequencing Facilitated Diagnosis of an Uncommon Patient Harboring Both Multiple Primary and Intrapulmonary Metastatic Lung Cancer: A Case Report

Multiple Primary Lung Cancers: A New Challenge in the Era of Precision Medicine.

Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 Therapy

Immunohistochemistry combined with NGS to assist the differential diagnosis of multiple primary lung cancer with lymph node metastasis: a case report

A Rare Case of Synchronous Multiple Primary Lung Cancer: Squamous Cell Cancer and Small Cell Lung Cancer